Lawsuit Alert: Investors who lost money with shares of Paragon 28, Inc. (NYSE: FNA) should contact the Shareholders Foundation

An investor, who purchased shares of Paragon 28, Inc. (NYSE: FNA), filed a lawsuit over alleged violations of Federal Securities Laws by Paragon 28, Inc. in connection with certain allegedly false and misleading statements.

Investors who purchased shares of Paragon 28, Inc. (NYSE: FNA) have certain options and for certain investors are short and strict deadlines running. Deadline: November 29, 2024. NYSE: FNA investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Englewood, CO based Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. Paragon 28, Inc. reported that its annual Total Revenue rose from $181.38 million in 2022 to $216.38 million in 2023, and that its Net Loss declined from $67.32 million in 2022 to $47.84 million in 2023.

On July 30, 2024, after the market closed, Paragon 28, Inc. filed a current report on Form 8-K with the SEC. It stated that "On July 30, 2024, the Audit Committee of the Board of Directors (the "Audit Committee") of Paragon 28, Inc. (the "Company"), in consultation with management, concluded that the Company's previously issued audited consolidated financial statements for the fiscal year ended December 31, 2023, contained within the Annual Report on Form 10-K for that year (and the associated audit report of the Company's independent registered accounting firm) and the unaudited condensed consolidated financial statements contained within the Quarterly Reports on Form 10-Q for the quarterly periods ended March 31, 2023, June 30, 2023, September 30, 2023, and March 31, 2024 should no longer be relied upon due to errors in such financial statements, and therefore a restatement of these prior financial statements is required. Accordingly, the Company intends to restate the aforementioned financial statements by amending its Annual Report on Form 10-K for the year ended December 31, 2023 and its quarterly report on Form 10-Q for the quarter ended March 31, 2024 (the "Restated Filings") as soon as reasonably practicable."

Shares of Paragon 28, Inc. (NYSE: FNA) declined $17.08 per share on August 02, 2023, to as low as $6.95 per share on July 31, 2024.

The plaintiff claims that between May 5, 2023 and August 8, 2024, the defendants made false and/or misleading statements and/or failed to disclose that Paragon 28's financial statements were misstated, that Paragon 28 lacked adequate internal controls and at times understated the extent of the issues with its internal controls, and that as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Those who purchased shares of Paragon 28, Inc. (NYSE: FNA) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.